---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-000135"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2022-01-06T23:59:59+00:00"
generated_at: "2026-06-27T20:09:23.942663+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Sonoma files investor presentation; no new material details visible in exhibit text

## Summary
- Furnished investor presentation under Item 7.01 for virtual conferences on Jan 10-13, 2022.
- Presentation text provided in filing is truncated and contains only standard disclaimers.
- No specific financial results, guidance, or business updates can be extracted from available text.
- Filing does not contain any earnings release, M&A, leadership change, or other material event.
- Investors should refer to the full presentation if made available elsewhere for potential updates.

## SEC filing metadata
- accession: 0001683168-22-000135
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2022-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316822000135/0001683168-22-000135-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316822000135/snoa_i8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-000135
- JSON: https://secwatch.observer/filing/0001683168-22-000135.json
- Plain text: https://secwatch.observer/filing/0001683168-22-000135.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.